Evidence map›Paper›PMID 24012679›Full record

ArticleThe American journal of pathology2013

Progesterone signaling inhibits cervical carcinogenesis in mice.

Young A Yoo, Jieun Son, Fabiola F Mehta, Francesco J DeMayo, John P Lydon, Sang-Hyuk Chung

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Review
  16. Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Epithelial estrogen receptor 1 intrinsically mediates squamous differentiation in the mouse vagina.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Young A YooCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Jieun SonCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Fabiola F MehtaCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Francesco J DeMayoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
John P LydonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Sang-Hyuk ChungCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas; McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: schung@uh.edu.
University of Houston · USBaylor College of Medicine · USUniversity of Wisconsin–Madison · US

Funding

Novel Interventions Against HPV-associated NeoplasiaU01CA141583 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F., MUNGER, KARL · 2009 to 2013
$3.8M
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCERR01CA077530 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LYDON, JOHN P · 2005 to 2008
$1.2M
Effectiveness and Patient Selection in Post-Hospital Brain Injury RehabilitationR03HD077495 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI MALEC, JAMES F. · 2014 to 2015
$154k
NCI NIH HHS CA141583NCI NIH HHS R01 CA077530NCI NIH HHS R01 CA-77530NCI NIH HHS U01 CA141583NICHD NIH HHS R03 HD077495NICHD NIH HHS U54 HD-0077495
6 · The paper itself

Abstract

Human papillomavirus is the main cause of cervical cancer, yet other nonviral cofactors are also required for the disease. The uterine cervix is a hormone-responsive tissue, and female hormones have been implicated in cervical carcinogenesis. A transgenic mouse model expressing human papillomavirus oncogenes E6 and/or E7 has proven useful to study a mechanism of hormone actions in the context of this common malignancy. Estrogen and estrogen receptor α are required for the development of cervical cancer in this mouse model. Estrogen receptor α is known to up-regulate expression of the progesterone receptor, which, on activation by its ligands, either promotes or inhibits carcinogenesis, depending on the tissue context. Here, we report that progesterone receptor inhibits cervical and vaginal epithelial cell proliferation in a ligand-dependent manner. We also report that synthetic progestin medroxyprogesterone acetate promotes regression of cancers and precancerous lesions in the female lower reproductive tracts (ie, cervix and vagina) in the human papillomavirus transgenic mouse model. Our results provide the first experimental evidence that supports the hypothesis that progesterone signaling is inhibitory for cervical carcinogenesis in vivo.

Indexed as

Signal TransductionAnimalsCarcinogenesisCarcinoma, Squamous CellCell DifferentiationCell ProliferationCervix UteriEpithelial CellsEpitheliumEstrogen Receptor alphaFemaleHumansMedroxyprogesterone AcetateMiceMice, TransgenicMucinsEstrogen Receptor alphaMedroxyprogesterone AcetateMucinsPapillomavirus E7 ProteinsProgesteroneReceptors, Progesterone

Identifiers

PMID24012679
PMCPMC3816255
OpenAlexW1989341973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.